Cargando…

263. Effect of Microbiologic Data on Prospective Audit and Feedback Recommendations

BACKGROUND: Prospective audit and feedback (PAF) is an effective method of antimicrobial stewardship. Given the time-intensive nature of PAF and low rates of intervention, understanding predictors of PAF recommendation and acceptance is imperative. Prior studies have not examined the impact of micro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bio, Laura, Kruger, Jenna, Schwenk, Hayden
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255290/
http://dx.doi.org/10.1093/ofid/ofy210.274
_version_ 1783373905465966592
author Bio, Laura
Kruger, Jenna
Schwenk, Hayden
author_facet Bio, Laura
Kruger, Jenna
Schwenk, Hayden
author_sort Bio, Laura
collection PubMed
description BACKGROUND: Prospective audit and feedback (PAF) is an effective method of antimicrobial stewardship. Given the time-intensive nature of PAF and low rates of intervention, understanding predictors of PAF recommendation and acceptance is imperative. Prior studies have not examined the impact of microbiologic data on the rate of PAF recommendation or recommendation acceptance. We evaluated whether antimicrobials prescribed for patients with positive microbiologic culture data were more or less likely to have a PAF recommendation and whether the presence of culture data impacted recommendation acceptance. METHODS: All PAF audits on antibiotic and antifungal medications for patients admitted to Lucile Packard Children’s Hospital Stanford between April 18, 2017 and April 17, 2018 were included. The PAF program included all pediatric units and injectable antimicrobials active for >48 hours. PAF documentation was completed in the electronic health record and included the presence or absence of positive microbiologic culture data. Our primary outcome was a comparison of PAF recommendation rate based on the presence or absence of positive culture data. We also evaluated whether there were differences in the recommendation acceptance rate and the type of recommendation based on the presence or absence of positive culture data. RESULTS: Of the 3,250 audits performed during the study period, 802 (25%) had positive cultures at the time of audit documentation. Of the 802 audits with positive cultures, 299 resulted in a recommendation compared with 824 of the 2,448 audits without positive cultures (37% vs. 34%, P = 0.07). PAF recommendations were more likely to be followed when positive culture data were present at the time of audit (80% vs. 73%, P = 0.03). The most common recommendation in the presence of positive culture data was to change the antimicrobial (27%) while the most common recommendation in the absence of positive culture data was to stop the antimicrobial (30%). CONCLUSION: The presence of positive microbiologic culture data did not impact the PAF recommendation rate. However, recommendations were more likely to be followed when there was concurrent positive culture data. This highlights the importance of obtaining culture data to direct antimicrobial therapy. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6255290
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62552902018-11-28 263. Effect of Microbiologic Data on Prospective Audit and Feedback Recommendations Bio, Laura Kruger, Jenna Schwenk, Hayden Open Forum Infect Dis Abstracts BACKGROUND: Prospective audit and feedback (PAF) is an effective method of antimicrobial stewardship. Given the time-intensive nature of PAF and low rates of intervention, understanding predictors of PAF recommendation and acceptance is imperative. Prior studies have not examined the impact of microbiologic data on the rate of PAF recommendation or recommendation acceptance. We evaluated whether antimicrobials prescribed for patients with positive microbiologic culture data were more or less likely to have a PAF recommendation and whether the presence of culture data impacted recommendation acceptance. METHODS: All PAF audits on antibiotic and antifungal medications for patients admitted to Lucile Packard Children’s Hospital Stanford between April 18, 2017 and April 17, 2018 were included. The PAF program included all pediatric units and injectable antimicrobials active for >48 hours. PAF documentation was completed in the electronic health record and included the presence or absence of positive microbiologic culture data. Our primary outcome was a comparison of PAF recommendation rate based on the presence or absence of positive culture data. We also evaluated whether there were differences in the recommendation acceptance rate and the type of recommendation based on the presence or absence of positive culture data. RESULTS: Of the 3,250 audits performed during the study period, 802 (25%) had positive cultures at the time of audit documentation. Of the 802 audits with positive cultures, 299 resulted in a recommendation compared with 824 of the 2,448 audits without positive cultures (37% vs. 34%, P = 0.07). PAF recommendations were more likely to be followed when positive culture data were present at the time of audit (80% vs. 73%, P = 0.03). The most common recommendation in the presence of positive culture data was to change the antimicrobial (27%) while the most common recommendation in the absence of positive culture data was to stop the antimicrobial (30%). CONCLUSION: The presence of positive microbiologic culture data did not impact the PAF recommendation rate. However, recommendations were more likely to be followed when there was concurrent positive culture data. This highlights the importance of obtaining culture data to direct antimicrobial therapy. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6255290/ http://dx.doi.org/10.1093/ofid/ofy210.274 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Bio, Laura
Kruger, Jenna
Schwenk, Hayden
263. Effect of Microbiologic Data on Prospective Audit and Feedback Recommendations
title 263. Effect of Microbiologic Data on Prospective Audit and Feedback Recommendations
title_full 263. Effect of Microbiologic Data on Prospective Audit and Feedback Recommendations
title_fullStr 263. Effect of Microbiologic Data on Prospective Audit and Feedback Recommendations
title_full_unstemmed 263. Effect of Microbiologic Data on Prospective Audit and Feedback Recommendations
title_short 263. Effect of Microbiologic Data on Prospective Audit and Feedback Recommendations
title_sort 263. effect of microbiologic data on prospective audit and feedback recommendations
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255290/
http://dx.doi.org/10.1093/ofid/ofy210.274
work_keys_str_mv AT biolaura 263effectofmicrobiologicdataonprospectiveauditandfeedbackrecommendations
AT krugerjenna 263effectofmicrobiologicdataonprospectiveauditandfeedbackrecommendations
AT schwenkhayden 263effectofmicrobiologicdataonprospectiveauditandfeedbackrecommendations